Keyphrases
Low-density Lipoprotein Cholesterol (LDL-C)
100%
US Adults
100%
Odds Ratio
77%
Atherosclerotic Cardiovascular Disease (ASCVD)
55%
Statins
33%
LDL-C Level
33%
Monoclonal Antibody
22%
Combination Therapy
22%
Ezetimibe
22%
High-intensity Statin
22%
PCSK9i
22%
Improved Outcomes
11%
Cerebrovascular Disease
11%
Disease Pattern
11%
Secondary Prevention
11%
US Healthcare System
11%
Peripheral Arterial Disease
11%
Young Age
11%
Community Practice
11%
Female Sex
11%
Black Race
11%
Statin Use
11%
Lipid-lowering Therapy
11%
Sex Odds
11%
Population Level
11%
C-factor
11%
Multivariable Modeling
11%
Clinical Trial Data
11%
Non-coronary Artery Disease
11%
Electronic Health Record Data
11%
Nonstatin Therapy
11%
High-intensity Statin Therapy
11%
Nursing and Health Professions
Odds Ratio
100%
Statin (Protein)
71%
Coronary Artery Atherosclerosis
71%
Combination Therapy
28%
Monoclonal Antibody
28%
Statins therapy
28%
Ezetimibe
28%
Practice Guideline
14%
Secondary Prevention
14%
Cerebrovascular Disease
14%
Peripheral Occlusive Artery Disease
14%
Electronic Health Record
14%
Artery Disease
14%
Pharmacology, Toxicology and Pharmaceutical Science
Statin (Protein)
100%
Coronary Artery Atherosclerosis
83%
Monoclonal Antibody
33%
Combination Therapy
33%
Ezetimibe
33%
Clinical Trial
16%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
16%
Cerebrovascular Disease
16%
Artery Disease
16%
Peripheral Occlusive Artery Disease
16%
Agricultural and Biological Sciences
Odds Ratio
100%
Cardiovascular System
71%
Monoclonal Antibody
28%
Likelihood
14%
Mathematics
Odds Ratio
100%
Population Level
14%